Related Experiment Video
Updated: Jun 14, 2025

Fluorescence Molecular Tomography for In Vivo Imaging of Glioblastoma Xenografts
Published on: April 26, 2018
Nuclear Medicine Imaging Techniques in Glioblastomas
Emirhan Harbi1, Michael Aschner2
1Department of Molecular Pharmacology, Albert Einstein College of Medicine, 1300 Morris Park Avenue, Bronx, NY, 10461, USA. emirhanharbi41@gmail.com.
Abstract:
Glioblastomas are the most common primary malignant grade 4 tumors of the central nervous system (CNS). The treatment and management of such tumors requires a multidisciplinary approach and nuclear medicine techniques play an important role in this process. Glioblastoma, which recurs despite current treatments and becomes resistant to treatments, is among the tumors with the lowest survival rate, with a survival rate of approximately 8 months. Currently, the standard treatment of glioblastoma is adjuvant chemoradiotherapy after surgical resection. There have been many recent advances in the field of Nuclear Medicine in glioblastoma. PET scans are critical in determining tumor localization, pre-surgical planning, evaluation of post-treatment response and detection of recurrence. Advances in the treatment of glioblastoma and a better understanding of the biological characteristics of the disease have contributed to the development of nuclear medicine techniques. This review, in addition to other studies, is intended as a general imaging summary guide and includes some new expressions discovered in glioblastoma. This review discusses recent advances in nuclear medicine in glioblastoma.
Insights
Nuclear medicine, particularly PET scans, is vital for diagnosing and managing glioblastoma, a severe brain tumor. Recent advancements enhance its role in treatment planning and recurrence detection.
Area of Science:
- Neuro-oncology
- Nuclear Medicine Imaging
- Central Nervous System (CNS) Tumors
Background:
- Glioblastoma is the most common and aggressive primary malignant grade 4 CNS tumor.
- It has a poor prognosis, with survival rates around 8 months, especially upon recurrence.
- Standard treatment involves surgery followed by chemoradiotherapy.
Purpose of the Study:
- To review recent advancements in nuclear medicine techniques for glioblastoma.
- To highlight the critical role of imaging in diagnosis, treatment planning, and monitoring.
- To provide a summary guide for nuclear medicine applications in glioblastoma.
Main Methods:
- Review of current literature and studies on nuclear medicine in glioblastoma.
- Focus on Positron Emission Tomography (PET) scan applications.
- Discussion of emerging nuclear medicine techniques and biomarkers.
Main Results:
- PET scans are essential for tumor localization, pre-surgical planning, and assessing treatment response.
- Nuclear medicine aids significantly in detecting glioblastoma recurrence.
- Recent advances improve the understanding and application of nuclear medicine in glioblastoma management.
Conclusions:
- Nuclear medicine plays an indispensable, evolving role in the multidisciplinary management of glioblastoma.
- Continued research is crucial for developing novel nuclear medicine strategies against glioblastoma.
- Enhanced imaging capabilities improve patient outcomes through precise diagnosis and monitoring.
Related Concept Videos
Imaging Studies II: Positron Emission Tomography and Scintigraphy
Fundamental Principles of PET
Magnetic Resonance Imaging
Brain Imaging
These technologies include computerized axial tomography (CAT or CT scans), positron-emission tomography (PET scans), magnetic resonance imaging (MRI), functional magnetic resonance imaging (fMRI), and Transcranial Magnetic...
Positron Emission Tomography
One of the main requirements of a PET scan is a positron-emitting radioisotope, which is produced in a cyclotron and then attached to a substance used by the part of the body...

